The differential expression and prognostic significance of KAT8 across glioma grades suggest that targeting KAT8 or its associated pathways could offer new avenues for glioma treatment, particularly in high‐grade tumours where its expression correlates with improved survival. The gene discussed is KAT8; the disease is neoplasm.